Skip to main content
. Author manuscript; available in PMC: 2014 May 27.
Published in final edited form as: Conf Proc IEEE Eng Med Biol Soc. 2006;1:775–778. doi: 10.1109/IEMBS.2006.259866

Fig. 3.

Fig. 3

Tn-C contents with CTGF treatment. Tn-C contents, a maker for ligament fibroblasts, were significantly increased by the treatment with 100 ng/ml CTGF and 50 μg/ml ascorbic acid by 2 & 4wks (n=3, *: p<0.01, **: p<0.001).